XML 111 R95.htm IDEA: XBRL DOCUMENT v3.3.1.900
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT Condensed Statements of Financial Position (Parent Company Only) (Details) - USD ($)
$ / shares in Units, $ in Thousands
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Current assets        
Cash and cash equivalents $ 13,859 $ 27,741 $ 34,275 $ 26,187
Prepaid and other current assets 10,608 7,281    
Total current assets 169,242 172,305    
Other assets        
Deferred financing fees (net of accumulated amortization of $6,670 and $4,700, respectively) 29,298 30,311    
Other 44,802 37,418    
Total other assets 1,303,241 1,290,398    
TOTAL ASSETS [1] 7,582,122 6,959,578 [2] 6,265,018 [2]  
Current liabilities        
Accounts payable 124,331 107,969    
Accrued payroll 24,123 23,502    
Accrued interest 52,577 50,538    
Debt maturing within one year 395,334 175,000    
Other 31,034 14,043    
Total current liabilities 719,153 463,014    
Accrued pension and postretirement liabilities 61,609 69,562    
Other 23,075 17,354    
Long-term debt (net of discounts of $3,404 and $3,940, respectively) 4,060,923 3,928,586    
STOCKHOLDERS’ EQUITY        
Common stock, without par value, 300,000,000 shares authorized, 152,699,077 and 155,140,967 shares issued and outstanding at December 31, 2015 and 2014, respectively 829,211 923,191    
Retained earnings 875,595 741,550    
Accumulated other comprehensive income 4,265 4,816 6,327 (18,048)
Total stockholders’ equity 1,709,071 1,669,557    
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 7,582,122 6,959,578    
Balance Sheet Additional Disclosures        
Deferred financing fees, accumulated amortization $ 17,515 $ 15,972    
Common stock, without par value $ 0 $ 0    
Common stock, shares authorized 300,000,000 300,000,000    
Common stock, shares issued 152,699,077 155,140,967    
Common stock, shares outstanding 152,699,077 155,140,967    
ITC Holdings Corp.        
Current assets        
Cash and cash equivalents $ 8,185 $ 6,305 $ 26,853 $ 22,546
Accounts receivable from subsidiaries 38,010 42,665    
Prepaid and other current assets 1,674 1,655    
Total current assets 47,869 50,625    
Other assets        
Investment in subsidiaries 4,010,767 3,784,609    
Deferred income taxes 21,241 25,887    
Deferred financing fees (net of accumulated amortization of $6,670 and $4,700, respectively) 12,322 14,117    
Other 64,098 67,376    
Total other assets 4,108,428 3,891,989    
TOTAL ASSETS 4,156,297 3,942,614    
Current liabilities        
Accounts payable 3,421 2,431    
Accrued payroll 24,123 23,502    
Accrued interest 34,836 34,815    
Debt maturing within one year 395,334 0    
Other 7,084 4,266    
Total current liabilities 464,798 65,014    
Accrued pension and postretirement liabilities 61,609 69,562    
Other 1,186 3,237    
Long-term debt (net of discounts of $3,404 and $3,940, respectively) 1,919,633 2,135,244    
STOCKHOLDERS’ EQUITY        
Common stock, without par value, 300,000,000 shares authorized, 152,699,077 and 155,140,967 shares issued and outstanding at December 31, 2015 and 2014, respectively 829,211 923,191    
Retained earnings 875,595 741,550    
Accumulated other comprehensive income 4,265 4,816    
Total stockholders’ equity 1,709,071 1,669,557    
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 4,156,297 3,942,614    
Balance Sheet Additional Disclosures        
Deferred financing fees, accumulated amortization 6,670 4,700    
Unamortized discount $ 3,404 $ 3,940    
Common stock, without par value $ 0 $ 0    
Common stock, shares authorized 300,000,000 300,000,000    
Common stock, shares issued 152,699,077 155,140,967    
Common stock, shares outstanding 152,699,077 155,140,967    
[1] Reconciliation of total assets results primarily from differences in the netting of deferred tax assets and liabilities at our Regulated Operating Subsidiaries as compared to the classification in our consolidated statements of financial position.
[2] Amounts reflect the change in the authoritative guidance on the presentation of deferred income taxes on the balance sheet. Refer to Notes 3 and 10 for more information.